Historical Vienna was the scene of this year’s annual congress of the European Society of Cardiology and several important issues in interventional cardiology were addressed.
First, one year after the annual congress in Barcelona, new and follow-up data on drug eluting stent (DES) safety were reported. The nation-wide SCAAR registry compiles data on all percutaneous coronary interventions in Sweden (> 37,000 DES implanted) and at this meeting the 4-year clinical outcomes were presented. Contrary to the 3-year clinical outcomes, a difference in mortality and myocardial infarction favouring bare metal stents (BMS) was no longer observed. Patrick Serruys tried to ...
CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR
August 7, 2020